Devonian Health Group provides more details on Previously Announced Positive Topline Results from Phase 2 Clinical trial of Thykamine™ in Adult Population with Mild-to-Moderate Atopic Dermatitis and the Grant of Stock Options

PRESS RELEASE For immediate release Devonian Health Group provides more details on Previously Announced Positive Topline Results from Phase 2 Clinical trial of Thykamine™ in Adult Population with Mild-to-Moderate Atopic Dermatitis and the Grant of Stock Options....

Devonian announces correction to press release issued July 28, 2020

PRESS RELEASE For immediate release DEVONIAN ANNOUNCES CORRECTION TO PRESS RELEASE ISSUED JULY 28, 2020.   QUEBEC, July 30, 2020 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation,...